(Puny volume, tiny movements, extremely low beta, no looming overhang )
Plain and simple…. Nothing to be excited about yet…. We have clouded sight ahead with seeing how the Adderall transition goes, we won’t know about overseas developments until they have developed, and need these few trials come through for additional undisclosed drugs….
Then maybe we begin earning some looks and investor interest